Word

IMMUNOCLOAK

Status

Pending

Status Code

686

Status Date

Tuesday, March 26, 2024

Serial Number

97822714

Mark Type

4000

Filing Date

Friday, March 3, 2023

Published for Opposition

Tuesday, March 26, 2024

Trademark Owner History

Breonics, Inc. - Owner At Publication

Classifications

5 Biochemical preparations for medical purposes, namely, bioengineered compounds for polymerized membranes to support organ and tissue transplantation; Biochemical preparations for medical purposes, namely, bioengineered compounds for polymerized membranes for use in organ and tissue transplantation; Biochemical preparations for medical purposes, namely, bioengineered membranes to support organ and tissue transplantation; Biochemical preparations for medical purposes, namely, bioengineered membranes for use in organ and tissue transplantation related applications; Biochemical preparations for medical purposes, namely, bioengineered membranes for use in reducing and preventing allorecognition; Biochemical preparations for medical purposes, namely, bioengineered membranes for use in reducing and preventing allorecognition in organ and tissue transplantation; Biochemical preparations for medical purposes, namely, bioengineered membrane containing collagen, vitrogen, fibronectin and laminin for organ and tissue transplantation, bioengineering tissue constructs to replace allografts and manufacturing immunomodified organs; Biochemical preparations for medical purposes, namely, bioengineered membrane that binds to the surface of blood vessels within the vasculature of an allograft; Biochemical preparations for medical purposes, namely, bioengineered membrane that binds to the surface of blood vessels within the vasculature of an allograft to support organ and tissue transplantation

1 Biochemical preparations for scientific purposes, namely, bioengineered compounds for polymerized membranes to support organ and tissue transplantation; Biochemical preparations for scientific purposes, namely, bioengineered compounds for polymerized membranes for use in organ and tissue transplantation; Biochemical preparations for scientific purposes, namely, bioengineered membranes to support organ and tissue transplantation; Biochemical preparations for scientific purposes, namely, bioengineered membranes for use in organ and tissue transplantation related applications; Biochemical preparations for scientific purposes, namely, bioengineered membranes for use in reducing and preventing allorecognition; Biochemical preparations for scientific purposes, namely, bioengineered membranes for use in reducing and preventing allorecognition in organ and tissue transplantation; Biochemical preparations for scientific purposes, namely, bioengineered membrane containing collagen, vitrogen, fibronectin and laminin; Biochemical preparations for scientific purposes, namely, bioengineered membrane that binds to the surface of blood vessels within the vasculature of an allograft; Biochemical preparations for scientific purposes, namely, bioengineered membrane that binds to the surface of blood vessels within the vasculature of an allograft to support organ and tissue transplantation

IMMUNO CLOAK

Trademark Events

Mar 26, 2024

Official Gazette Publication Confirmation E-Mailed

Mar 26, 2024

Published For Opposition

Mar 6, 2024

Notification Of Notice Of Publication E-Mailed

Mar 6, 2024

Official Gazette Publication Confirmation E-Mailed

Feb 21, 2024

Approved For Pub - Principal Register

Feb 16, 2024

Teas/Email Correspondence Entered

Feb 16, 2024

Correspondence Received In Law Office

Feb 16, 2024

Teas Response To Office Action Received

Feb 16, 2024

Teas Withdrawal Of Attorney Received-Firm Retains

Feb 16, 2024

Teas Change Of Correspondence Received

Feb 16, 2024

Attorney/Dom.Rep.Revoked And/Or Appointed

Feb 16, 2024

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

Dec 8, 2023

Notification Of Priority Action E-Mailed

Dec 8, 2023

Priority Action E-Mailed

Dec 8, 2023

Priority Action Written

Dec 1, 2023

Assigned To Examiner

Mar 23, 2023

New Application Office Supplied Data Entered